Immuneering Corp (IMRX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$59.38M | +7.3% |
| 2024 | -$64.07M | -9.7% |
| 2023 | -$58.41M | -12.9% |
| 2022 | -$51.74M | -52.7% |
| 2021 | -$33.89M | -98.4% |
| 2020 | -$17.08M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$59.38M | +7.3% |
| 2024 | -$64.07M | -9.7% |
| 2023 | -$58.41M | -12.9% |
| 2022 | -$51.74M | -52.7% |
| 2021 | -$33.89M | -98.4% |
| 2020 | -$17.08M | — |